295 related articles for article (PubMed ID: 16358615)
61. Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis.
Heemskerk-Gerritsen BA; Menke-Pluijmers MB; Jager A; Tilanus-Linthorst MM; Koppert LB; Obdeijn IM; van Deurzen CH; Collée JM; Seynaeve C; Hooning MJ
Ann Oncol; 2013 Aug; 24(8):2029-35. PubMed ID: 23576707
[TBL] [Abstract][Full Text] [Related]
62. Women at high risk for breast cancer: preventive strategies.
Sakorafas GH
Mt Sinai J Med; 2002 Sep; 69(4):264-6. PubMed ID: 12357269
[TBL] [Abstract][Full Text] [Related]
63. Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?
Kotsopoulos J; Narod SA
Expert Rev Anticancer Ther; 2018 Mar; 18(3):199-200. PubMed ID: 29308680
[No Abstract] [Full Text] [Related]
64. Contralateral risk-reducing mastectomy in young women.
Merck B
Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():29-32. PubMed ID: 20711671
[No Abstract] [Full Text] [Related]
65. Indications for prophylactic mastectomy.
Nemecek JR; Young VL; Lopez MJ
Mo Med; 1993 Mar; 90(3):136-40. PubMed ID: 8446090
[TBL] [Abstract][Full Text] [Related]
66. Prophylactic bilateral mastectomy and contralateral prophylactic mastectomy.
Chagpar AB
Surg Oncol Clin N Am; 2014 Jul; 23(3):423-30. PubMed ID: 24882342
[TBL] [Abstract][Full Text] [Related]
67. [Preventive bilateral mastectomy--future treatment of women with high risk of breast cancer].
Petersson B; Klinken L
Ugeskr Laeger; 2000 Jun; 162(26):3735. PubMed ID: 10925636
[No Abstract] [Full Text] [Related]
68. 'That's like chopping off a finger because you're afraid it might get broken': disease and illness in women's views of prophylactic mastectomy.
Press N; Reynolds S; Pinsky L; Murthy V; Leo M; Burke W
Soc Sci Med; 2005 Sep; 61(5):1106-17. PubMed ID: 15955410
[TBL] [Abstract][Full Text] [Related]
69. [Women with hereditary risk of breast cancer: consensus of surgical representatives of study groups for hereditary tumors regarding intensive monitoring, diagnosis and preventive resection].
van Geel AN; Rutgers EJ; Vos-Deckers GC; de Vries J; Wobbes T
Ned Tijdschr Geneeskd; 1997 May; 141(18):874-7. PubMed ID: 9273451
[TBL] [Abstract][Full Text] [Related]
70. A protocol for preventative mastectomy in women with an increased lifetime risk of breast cancer.
Lalloo F; Baildam A; Brain A; Hopwood P; Evans DG; Howell A
Eur J Surg Oncol; 2000 Nov; 26(7):711-3. PubMed ID: 11078619
[TBL] [Abstract][Full Text] [Related]
71. Time to reconsider subcutaneous mastectomy for breast-cancer prevention?
Metcalfe KA; Semple JL; Narod SA
Lancet Oncol; 2005 Jun; 6(6):431-4. PubMed ID: 15925821
[TBL] [Abstract][Full Text] [Related]
72. Prophylactic mastectomy and inherited predisposition to breast carcinoma.
Hughes KS; Papa MZ; Whitney T; McLellan R
Cancer; 1999 Dec; 86(11 Suppl):2502-16. PubMed ID: 10630176
[TBL] [Abstract][Full Text] [Related]
73. When is contralateral mastectomy warranted in unilateral breast cancer?
Barry M; Sacchini V
Expert Rev Anticancer Ther; 2011 Aug; 11(8):1209-14. PubMed ID: 21916574
[TBL] [Abstract][Full Text] [Related]
74. Breast cancer: management of the opposite breast.
Moffat FL; Ketcham AS; Robinson DS; Legaspi A; Irani H
Oncology (Williston Park); 1988 Nov; 2(11):25-30, 33. PubMed ID: 3275042
[TBL] [Abstract][Full Text] [Related]
75. Prophylactic mastectomy versus surveillance for the prevention of breast cancer in women's BRCA carriers.
Honold F; Camus M
Medwave; 2018 Jul; 18(4):e7161. PubMed ID: 30052622
[TBL] [Abstract][Full Text] [Related]
76. [BRCA mutations: from Angelina Jolie to specific therapies].
Lopez VA; Stravodimou A; Unger S; Perey L; Zaman K
Rev Med Suisse; 2016 May; 12(519):973-4, 976-7. PubMed ID: 27424423
[TBL] [Abstract][Full Text] [Related]
77. Preoperative diagnosis of BRCA1/2 mutation impacts decision-making for risk-reducing mastectomy in breast cancer patients.
Woo J; Gwak G; Park I; Bae BN; Lee SK; Chae BJ; Yu J; Lee JE; Kim SW; Nam SJ; Ryu JM
Sci Rep; 2021 Jul; 11(1):14747. PubMed ID: 34285295
[TBL] [Abstract][Full Text] [Related]
78. Bilateral prophylactic mastectomy in women with an increased risk of breast cancer.
Tecnologica MAP Suppl; 1999 Jun; ():3-6. PubMed ID: 10848037
[No Abstract] [Full Text] [Related]
79. Patient-Reported Outcome Measures may optimize shared decision-making for cancer risk management in BRCA mutation carriers.
van Egdom LSE; de Kock MA; Apon I; Mureau MAM; Verhoef C; Hazelzet JA; Koppert LB
Breast Cancer; 2020 May; 27(3):426-434. PubMed ID: 31832891
[TBL] [Abstract][Full Text] [Related]
80. Review of 54-year-old man with breast cancer after prolonged testosterone therapy.
Krause W
Clin Adv Hematol Oncol; 2005 Sep; 3(9):714. PubMed ID: 16224446
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
